FDA Investigator Nancy A Saxenian Emmons

Nancy A Saxenian Emmons has inspections in 5 countries as of 24 Oct 2023. Nancy A Saxenian Emmons has collaborated with a combined 4162 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
108
Last Inspection Date:
24 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100003711
Country:
United States of America, Switzerland, Belgium, United Kingdom of Great Britain and Northern Ireland, Canada
Co-Investigator(s):
Aldo J Milone, Alexander M Kay, Alexandria L Capuano, Althea A Williams, Amal M Mansour, Andrew F Cohen, Anita Narula, PhD, Ann B Okon, Anne Marie Dubrey, Arduino Frankovic, Arie C Menachem, Ashleigh P Barkans, Ashley Polizzotto, Astrida B Mattson, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Benton M Ketron, Bo Chi, PhD, Brenda L Reihing, Brian A Perkins, Bruce G Cooper, Bryce E Mansfield, Burnell M Henry, Carl A Anderson, Carolyn J Cook, Cassandra L Abellard, Catherine J Laufmann, Catherine M Beer, Celia L Silverstein, Christina V Santos, Christopher S Genther, Connie P Rezendes, Crystal A Harlan, Cynthia J Lee, MS, Cynthia L Gorveatt, Dana A Razzano, Daniel L Aisen, Daryl A Dewoskin, Dave M Deroche, David A Oluwo, David J Gomes, David M Mcnew, David R Delucia, Dawn E Barkans, Deborah A Nebenzahl, Demitria J Xiradakis, Denise L Terzian, Dennis G Kawabata, Devon M Shoop, Dipesh K Shah, Dolores E Price, Don H Bark, PhD, Donald B Mckechnie, Donald C Obenhuber, PhD, Donald G Gordon, Donald J Ullstrom, Douglas G Ng, Dr. Guang Gao, PhD, Edmund F Mrak, Jr, Eileen A Liu, Elizabeth S Howell, Ellen M Landis, Emilio Z Azukwu, Gary L Zaharek, Gary T Greco, Gene D Arcy, George C Amedro, Gerald B Seaborn, Jr, Ginger M Sykes, Gloria J Baca, MS, Graham N Giesen, Gregson A Joseph, Harperd, Harry J Brewer, Heika R Tait, Huascar Batista, Ismael Olvera, IV, Jacqueline S Warner, James A Lane, James A Liubicich, James D Bridges, James D Hildreth, James K Ireland, Jane Chen, Jane M Kreis, Janet L Bowen, Javier O Vega, Jocelyn T Ramos, Joel D Hustedt, Joel R Merriman, John A Gonzalez, John A Podsadowski, John Burr, John E Emmert, Jose Alopez Rubet, Joshua D Lopez, Joshua P Wireman, Joy P Matthias, Judy Keihl, Julian C Hanson, Juliana Falla, Karen A Briggs, Katherine D Adams, Katherine E Jacobitz, Kathryn A Krentz, Kelsey M Bishop, Kenneth A Miles, Kenneth G Klobus, Kenneth H Williams, Kenneth M Gordon, Kevin A Gonzalez, Kevin D Kallander, Khang K Pham, Kimberly Y Smithson, Kristopher J Stanya, PhD, Kwong P Lee, Lance W Bohm, Lawrence H Patrick, Lawrence W Farina, Lawrence Y Lee, PhD, LCDR Chad N Thompson, Lewis K Antwi, Linan Ha, PhD, Linda K Cline, Linda S Leja, Lisa K Capron, Lisa Mathew, Lori J Silverstein, Lorna F Jones, Lucas B Leake, Lydia Irosas Marty, Margaret E Sarles, Maria Pkelly Doggett, MBA, Marie A Fadden, Marjorie A Shapiro, PhD, Mary M Finn, Matthew A Spataro, Meisha A Mandal, Melissa A Henaghan, Melissa N Gregorio, Meyer J Slobotsky, Michael A Charles, Michael G Sinkevich, Michael Levin, Michael P Sheehan, Michael R Dominick, Michael R Goga, Michael W Burd, Michelle L Dragon Nagel, Miguel A Martinez, Mihaly S Ligmond, Mikel T Wright, Milan S Mcgorty, Mindy M Chou, Misty L Treece, Morris Paul, Mouhamed H Halwani, Mra Davism, Nancy A Saxenian, Nancy A Sayenare, Nancy E Byerly, Nancy L Rolli, Nicholas C Mendiola, Norman Wong, Omotunde O Osunsanmi, Paul E Stein, Paul F Rader, Paul L Figarole, Jr, Paul M Kawamoto, Paul Mouris, Paul Rader, Paula A Trost, Perez, Peter Kessler, PhD, Peter M Trunk, Peter R Caparelli, Philip E Ake, Prabhu P Raju, Rajiv R Srivastava, Randi Lynn Spencer, Raymond M Lam, Rebecca E Dombrowski, Rebecca L Stephany, Rebecca Rodriguez, Rebecca T Davis, Regina T Brown, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Veitch, Rocco C Black, Roger F Zabinski, Rowena S Nguyen, Russ E Davis, S Lori Brown, PhD MPH, Samuel M Salerno, Samuel T Walker, Sangeeta M Khurana, PhD, Sara H Gabel, Sasha M Latonis, Satheesh Thomas, Savini, Scott A Nabe, Scott R Izyk, Sharon I Gundersen, Sherri N Rohlf, MD, Simone E Pitts, Sony Mathews, Stanley B Eugene, BS, BME, Stanley E Malcolm, State Agency, Stephen R Souza, Steven A Gonzales, Sung K Kim, Sunitha K Rajaram, PhD, Susanna E Ford, Analyst, Tamara M Simpson, Terri L Dodds, Thomas J Arista, Thomas P Hansen, Todd A Manning, Tracy K Li, Tracy M Portelli, Uduak M Inokon, Valerie A Potopsingh, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Victor A Meo, Wayne S Thompson, Wendy M Stone, William C Hughes, William M Rennells, William P Chilton, Xiaojun Yan, Xiaokuang Lai, PhD, Yumi J Hiramine, Yvonne M Santiago, Zachary L Miller

Nancy A Saxenian Emmons's Documents

Publish Date Document Type Title
September, 2000 FDA 483 Bimeda-MTC Animal Health - Form 483, 2000-09-14
December, 2003 EIR Micro-Macinazione SA - EIR, 2003-12-12
October, 2002 FDA 483 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - Form 483, 2002-10-24
February, 2006 EIR WCG IRB, Inc - EIR, 2006-02-06
February, 2003 EIR Monaghan Medical Corporation - EIR, 2003-02-26
March, 2000 EIR Leonard B. Saltz, M.D. Clinical Investigator - EIR, 2000-03-31
March, 2006 FDA 483 Westone Laboratories, Inc. - Form 483, 2006-03-29
December, 2003 FDA 483 Response Micro-Macinazione SA - Form 483R, 2004-02-11
October, 2001 EIR GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - EIR, 2001-10-11
September, 2000 EIR Bimeda-MTC Animal Health - EIR, 2000-09-14
September, 2000 EIR Patheon Inc. - EIR, 2000-09-07
October, 2002 EIR GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - EIR, 2002-10-24
May, 2001 FDA 483 Datwyler Pharma Packaging - Form 483, 2001-05-23
March, 2000 FDA 483 Daniel J. O'Dea, MD, Clinical Investigator - Form 483, 2000-03-03
September, 2003 FDA 483 Clinical Encapsulation Service - Form 483, 2003-09-26
December, 2003 EIR Micro-Macinazione SA - EIR, 2003-12-16
January, 2003 EIR James Arthur Holland - EIR, 2003-01-03
September, 2000 FDA 483 Response Bimeda-MTC Animal Health - Form 483R, 2000-09-24
May, 2003 FDA 483 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - Form 483, 2003-05-13
May, 2001 EIR Datwyler Pharma Packaging - EIR, 2001-05-23
May, 2003 EIR GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - EIR, 2003-05-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more